Assisted standing for Duchenne muscular dystrophy

被引:7
|
作者
Pedlow, Katy [1 ,2 ]
McDonough, Suzanne [1 ,2 ]
Lennon, Sheila [3 ]
Kerr, Claire [4 ]
Bradbury, Ian [5 ]
机构
[1] Ulster Univ, Ctr Hlth & Rehabil Technol CHaRT, Inst Nursing & Hlth Res, Room 1Fl10,Shore Rd, Newtownabbey BT37 0QB, Antrim, North Ireland
[2] Royal Coll Surgeons Ireland, Physiotherapy, Dublin, Ireland
[3] Flinders Univ S Australia, Coll Nursing & Hlth Sci, Physiotherapy, Adelaide, SA, Australia
[4] Queens Univ Belfast, Sch Nursing & Midwifery, Belfast, Antrim, North Ireland
[5] Frontier Sci Scotland, Kincraig, Scotland
来源
COCHRANE DATABASE OF SYSTEMATIC REVIEWS | 2019年 / 10期
关键词
ANKLE-FOOT ORTHOSES; PREDICTIVE FACTORS; SCOLIOSIS; CHILDREN; MANAGEMENT; PRESCRIPTION; PROLONGATION; LIGHTWEIGHT; EXPERIENCE; SURVIVAL;
D O I
10.1002/14651858.CD011550.pub2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Duchenne muscular dystrophy (DMD) is the most common X-linked neuromuscular disorder. When boys with DMD reach the second decade of life, they lose their ability to walk and become wheelchair dependent. Standing devices and orthoses are considered to be an essential component in the therapy management of DMD. Clinical opinion and research from other neurological conditions highlight the proposed benefits of standing device use, however, its effect within this population is currently unknown. A review of the evidence for the use of standing devices and orthoses is necessary to inform all stakeholders, including people with DMD, clinicians, decision makers and funders, and to guide future research. Objectives To assess the effects of standing devices and orthoses on musculoskeletal impairments (such as pain, contracture, scoliosis development and bone density) in boys and men with DMD, and secondarily to determine their effect on quality of life, participation in activities, and patient experience (satisfaction). We also considered any adverse events associated with their use. Search methods We searched the Cochrane Neuromuscular Specialised Register, CENTRAL, MEDLINE, Embase, AMED, PsycINFO, CINAHL Plus, PEDro, and ProQuest Dissertations & Theses Global up to 5 September 2019. We checked references in identified trials, handsearched journal abstracts, and searched trials registries. Selection criteria We planned to include randomised controlled trials (RCTs) and quasi-RCTs of any model of standing device for use in DMD. The control interventions would have been any other comparison group, including no standing device, a different model of standing device, usual care, or an alternative form of assistive weight bearing. Data collection and analysis We used standard Cochrane methodological procedures. Main results Although we identified 13 potentially relevant studies, none met the inclusion criteria for this review. Authors' conclusions Since there were no RCTs or quasi-RCTs available to evaluate the effectiveness of standing devices in people with DMD, studies are needed to investigate the effectiveness of standing devices in this population.
引用
收藏
页数:21
相关论文
共 50 条
  • [31] Nanotherapy for Duchenne muscular dystrophy
    Nance, Michael E.
    Hakim, Chady H.
    Yang, N. Nora
    Duan, Dongsheng
    WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2018, 10 (02)
  • [32] Duchenne muscular dystrophy pathophysiology
    Pereon, Y.
    Mercier, S.
    Magot, A.
    ARCHIVES DE PEDIATRIE, 2015, 22 : S18 - S23
  • [33] DUCHENNE MUSCULAR-DYSTROPHY
    HOFFMAN, EP
    RECHERCHE, 1993, 24 (250): : 36 - 44
  • [34] DUCHENNE MUSCULAR-DYSTROPHY
    BERROL, S
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1976, 235 (12): : 1212 - 1212
  • [35] REGENERATION IN DUCHENNE MUSCULAR DYSTROPHY
    MASTAGLI.FL
    PAPADIMI.JM
    KAKULAS, BA
    AUSTRALASIAN ANNALS OF MEDICINE, 1968, 17 (02): : 172 - &
  • [36] Duchenne or Meryon muscular dystrophy?
    Drouin, Emmanuel
    Pereon, Yann
    MOLECULAR GENETICS AND METABOLISM, 2014, 113 (04) : 241 - 242
  • [37] Adults with Duchenne Muscular Dystrophy
    Eagle, Michelle
    Straub, Volker
    Bushby, Kate
    NEUROMUSCULAR DISORDERS, 2006, 16 : S120 - S120
  • [38] Challenges in Duchenne muscular dystrophy
    Davies, KE
    NEUROMUSCULAR DISORDERS, 1997, 7 (08) : 482 - 486
  • [39] Osteopontin in Duchenne Muscular Dystrophy
    Pegoraro, Elena
    Bello, Luca
    Piva, Luisa
    Barp, Andrea
    Ermani, Mario
    Politano, Luisa
    Mercuri, Eugenio
    Previtali, Stefano
    Torrente, Yvan
    Bruno, Claudio
    Minetti, Carlo
    Berardinelli, Angela
    Comi, Giacomo
    D'Amico, Adele
    Soraru', Gianni
    Messina, Sonia
    Mongini, Tiziana
    Bertini, Enrico
    Ferlini, Alessandra
    Gualandi, Francesca
    Battini, Roberta
    Boffi, Patrizia
    Pane, Marika
    Vita, Giuseppe
    Hoffman, Eric
    Angelini, Corrado
    NEUROLOGY, 2012, 78
  • [40] Duchenne muscular dystrophy and epilepsy
    Costa, L. M.
    Barcelos, B. C.
    Cruz, A. R. S.
    Pereira, V. B. P.
    Godoy, A. J.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S300 - S300